Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

Blood (2019) 134 (Supplement_1): 840.

https://doi.org/10.1182/blood-2019-130009

Published: 2019

Journal Articles

A Retrospective Analysis of Patients Presenting with Eosinophilia and Strongyloidiasis

Anisha Rajavel, BS, Sunit P Jariwala, MD

Blood (2018) 132 (Supplement 1): 4943.

https://doi.org/10.1182/blood-2018-99-113543

Published: 2018

Journal Articles

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Sandhya R. Panch, Michael E. Bozik, Thomas Brown, Michelle Makiya, Calman Prussin, Donald G. Archibald, Gregory T. Hebrank, Mary Sullivan, Xiaoping Sun, Lauren Wetzler, JeanAnne Ware, Michael P. Fay, Cynthia E. Dunbar, Steven I. Dworetzky, Paneez Khoury, Irina Maric, Amy D. Klion

Blood (2018) 132 (5): 501–509.

https://doi.org/10.1182/blood-2018-02-835330

Published: 2018

Includes: Supplemental data

Journal Articles

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Sikander Ailawadhi, Abdel-Ghani Azzouqa, Zahara Meghji, Tania Jain, MD, Nancy Diehl, Stephanie P. Gebhardt, Vishal Shah, David O. Hodge, MS, Raj Patel, MD, Prachi Jani, MD, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Rafael Fonseca, MD

Blood (2017) 130 (Supplement 1): 5440.

https://doi.org/10.1182/blood.V130.Suppl_1.5440.5440

Published: 2017

Journal Articles

Recreating the Hematopoietic Microenvironment in Vitro Using Microfluidic “on-a-Chip” Technology Enables the Study of Interactions of Normal and Malignant HSPC with Specific Bone Marrow Niches

Sunil George, PhD, Julio Aleman, MS, M. Graca Almeida-Porada, MD PhD, Aleksander Skardal, PhD, Christopher D Porada, PhD

Blood (2017) 130 (Supplement 1): 3779.

https://doi.org/10.1182/blood.V130.Suppl_1.3779.3779

Published: 2017

Journal Articles

Detection of Antibodies in Serum and Lymphocytes of Patients with Hemorraghic Fever with Renal Syndrome

Ekaterina E. Garanina, PhD, Egor V. Okhezin, Ekaterina V. Martynova, MD PhD, Venera G. Shakirova, PhD MD, Albert Rizvanov, DSc, PhD, Svetlana Khaiboullina, DrSci, MD

Blood (2017) 130 (Supplement 1): 4824.

https://doi.org/10.1182/blood.V130.Suppl_1.4824.4824

Published: 2017

Journal Articles

Prevalence of Stronglyoides Stercoralis and Elevated Immunoglobulin E in Patients with Eosinophilia in a New York City Physician's Practice

Mala Varma, MD, Aungthet Min, Joseph Yoe, MD

Blood (2017) 130 (Supplement 1): 4808.

https://doi.org/10.1182/blood.V130.Suppl_1.4808.4808

Published: 2017

Journal Articles

Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study

Sandhya R. Panch, MD MPH, Michael Bozik, MD, Thomas Brown, RN, Ulrike Demarco, Dipl. Biol., Jamie Hahn, BS, Alexander Komarov, PhD, Tamika Magee, RN, Michelle Makiya, RN, Calman Prussin, MD, Armando Signore, PhD, Mary Sullivan, BA, Lauren Wetzler, MHS, PA, Cynthia E. Dunbar, MD, Steven Dworetzky, PhD, Irina Maric, MD, Amy D Klion, MD

Blood (2016) 128 (22): 1327.

https://doi.org/10.1182/blood.V128.22.1327.1327

Published: 2016

Journal Articles

Mutation Analysis in 200 Cases of Newly Diagnosed Myelodysplastic Syndrome By Next Generation Sequencing: Association with Established Prognostic Variables and IPSS-R

Kankana Ghosh, B. Pharm, Parsa Hodjat, MD, Priyanka Priyanka, MPH, Beenu Thakral, MBBS,MD, Keyur P. Patel, MD PhD, Mark Routbort, MD PhD, Rashmi Kanagal-Shamana, MD, C. Cameron Yin, MDPhD, Zhuang Zuo, MD PhD, Raja Luthra, PhD, Tariq Muzzafar, MD

Blood (2015) 126 (23): 1703.

https://doi.org/10.1182/blood.V126.23.1703.1703

Published: 2015

Journal Articles

Increased NKT-like Cells and Markers of T Cell Activation in Long Term Survivors of Allogeneic Hematopoietic Cell Transplantation

Shernan G. Holtan, MD, Laura Newell, MD, Rachel J Cook, MD MS, Kaitlin Pataroque, Nicky Leeborg, MD, Richard T. Maziarz, MD, Guang Fan, MD PhD

Blood (2014) 124 (21): 3958.

https://doi.org/10.1182/blood.V124.21.3958.3958

Published: 2014

Journal Articles

Unraveling a novel transcription factor code determining the human arterial-specific endothelial cell signature

Xabier L. Aranguren, Xabier Agirre, Manu Beerens, Giulia Coppiello, Maialen Uriz, Ine Vandersmissen, Mohammed Benkheil, Joaquin Panadero, Natalia Aguado, Alberto Pascual-Montano, Victor Segura, Felipe Prósper, Aernout Luttun

Blood (2013) 122 (24): 3982–3992.

https://doi.org/10.1182/blood-2013-02-483255

Published: 2013

Includes: Supplemental data

Journal Articles

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Ann Brinch Madelung, MD, Michael Bzorek, MT, Henrik Bondo, MD, Eva M.K. Zetterberg, MD, PhD, Ole Weis Bjerrum, MD, DMSc, Hans Carl Hasselbalch, MD, DMSc, Stefan Scheding, MD, Elisabeth Ralfkiaer, Prof., MD, DMSc

Blood (2010) 116 (21): 4108.

https://doi.org/10.1182/blood.V116.21.4108.4108

Published: 2010

Journal Articles

Hypereosinophilia in 357 Consecutive Patients: Disease Spectrum and Clinical and Laboratory Correlates.

Ken-Hong Lim, MD, Ayalew Tefferi, MD, Chin Yang Li, MD, Animesh D. Pardanani, MBBS, PhD

Blood (2009) 114 (22): 3903.

https://doi.org/10.1182/blood.V114.22.3903.3903

Published: 2009

Journal Articles

’Idiopathic’ Eosinophilia with an Occult T-Cell Clone: Prevalence, FIP1L1-PDGFRA Status, and Clinical Course.

Animesh Pardanani, MD, PhD, Christos Vaklavas, MD, Joseph Butterfield, MD, Rhett Ketterling, MD, Srdan Verstovsek, MD, PhD, Hagop Kantarjian, MD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 2701.

https://doi.org/10.1182/blood.V108.11.2701.2701

Published: 2006

Journal Articles

Alemtuzumab (CAMPATH-1H ™ ) Is Effective Therapy for Hypereosinophilic Syndrome (HES).

Alfonso Quintas-Cardama, MD, Ayalew Tefferi, M.D., Jorge Cortes, M.D., Animesh Pardanani, M.D., Farhad Ravandi-Kashani, M.D., Francis Giles, M.D., Pat Ault, R.N., Hagop Kantarjian, M.D., Srdan Verstovsek, M.D.;PhD

Blood (2006) 108 (11): 4902.

https://doi.org/10.1182/blood.V108.11.4902.4902

Published: 2006

Journal Articles

Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children’s Oncology Group Study.

David A. Jacobsohn, MD, Kirk R. Schultz, MD, Frederick Goldman, MD, Donna A. Wall, MD, Mark Krailo, PhD, Zhengjia Chen, MS, Jeffrey M. Lipton, MD, PhD, Jean E. Sanders, MD, Andrew L. Gilman, MD

Blood (2005) 106 (11): 5375.

https://doi.org/10.1182/blood.V106.11.5375.5375

Published: 2005

NARROW

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

A Retrospective Analysis of Patients Presenting with Eosinophilia and Strongyloidiasis

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Recreating the Hematopoietic Microenvironment in Vitro Using Microfluidic “on-a-Chip” Technology Enables the Study of Interactions of Normal and Malignant HSPC with Specific Bone Marrow Niches

Detection of Antibodies in Serum and Lymphocytes of Patients with Hemorraghic Fever with Renal Syndrome

Prevalence of Stronglyoides Stercoralis and Elevated Immunoglobulin E in Patients with Eosinophilia in a New York City Physician's Practice

Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study

Mutation Analysis in 200 Cases of Newly Diagnosed Myelodysplastic Syndrome By Next Generation Sequencing: Association with Established Prognostic Variables and IPSS-R

Increased NKT-like Cells and Markers of T Cell Activation in Long Term Survivors of Allogeneic Hematopoietic Cell Transplantation

Unraveling a novel transcription factor code determining the human arterial-specific endothelial cell signature

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Hypereosinophilia in 357 Consecutive Patients: Disease Spectrum and Clinical and Laboratory Correlates.

’Idiopathic’ Eosinophilia with an Occult T-Cell Clone: Prevalence, FIP1L1-PDGFRA Status, and Clinical Course.

Alemtuzumab (CAMPATH-1H ™ ) Is Effective Therapy for Hypereosinophilic Syndrome (HES).

Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children’s Oncology Group Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only